ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Hq spclt pharma Patent: 6,528,540 Expiration: Jan 12, 2021 See More … For more information on how DrugPatentWatch can help with…
The post Drug Patent Expirations for the…
Drug Patent Expirations for the Week of January 10, 2021 Read Post »
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are sixteen patents protecting this drug. This drug…
The post New patent for Amicus Theraps drug GALAFOLD appeared first on D…
Annual Drug Patent Expirations for JUBLIA Jublia is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent for Bausch drug JUBLIA appeared first on DrugPatentWat…
Annual Drug Patent Expirations for ZIOPTAN Zioptan is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for AKORN drug ZIOPTAN appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one…
The post New patent expiration for Hq S…
New patent expiration for Hq Spclt drug ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER Read Post »
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available…
The post New pat…
This chart shows the pharmaceutical companies with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in Japan? Read Post »
This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…
The post Which pharmaceutical companies ha…
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug p…
Which pharmaceutical companies have the most drug patents in Luxembourg? Read Post »
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Clovis Oncology drug RUBRACA appeared first…
New patent expiration for Clovis Oncology drug RUBRACA Read Post »
Get new actionable insights and updates from BiotechBlog
